Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2019

View Archived Issues

New mouse model for intrahepatic cholangiocellular carcinoma reveals protective effect of Pecam-1

Signaling promotes glucose uptake, brain tumor development

Novel Dyrk1 inhibitor DYR-219 delays the onset of AD-like pathology in 3xTg-AD mice

Artesunate modifies T cells to protect against type 1 diabetes

SNP-162 inhibits growth of sorafenib-resistant liver cancer cell lines

CStone completes registration filing in Australia for phase I trial of CS-3002 in solid tumors

NO-releasing polymer NVN-1000 inhibits HPV DNA replication and progeny virus production

MEIS2 knockdown prevents colorectal cancer cell migration and invasion

Monoclonal antibody P52E03 protects against H7N9 virus challenge

Transgenic expression of human STING mutant in hematopoietic cells provides murine SAVI model

Enrollment ongoing in phase II study of osilodrostat in pediatric patients with Cushing's disease

FIAsp receives European approval for the management of diabetes in adolescents and children

Tanabe initiates first-in-human study of TR1801-ADC

Off-target resistance to TRK inhibitors

Sunshine Lake Pharma describes new farnesoid X receptor agonists

Otago Innovation, University of Copenhagen patent CaMK2A ligands

Anhui New Star Pharmaceutical Development discovers P2Y12 antagonists

New IDO-1 inhibitors identified at Hinova Pharmaceuticals

Boehringer Ingelheim presents ghrelin O-acyltransferase inhibitors

Daewoong's pulmonary fibrosis drug DWN-12088 enters global phase I trial

Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...